|
To detect and quantify patient hemostasis
imbalance, to identify the specific hemostatic components causing it,
and to determine the treatment necessary to restore it, Haemoscope has
developed a Decision Tree. It allows a clinician to follow a
hierarchical map for guidance in diagnosis and, subsequently, therapy.
This diagram represents a high level view of the decisions made in
arriving at a diagnosis:
This decision tree, using results from TEG®
analysis, helps identify the coagulopathy and in the case of
fibrinolysis, can distinguish between primary and secondary
fibrinolysis. The TEG® system is unique in that it can easily
distinguish between the two. In the case of hypercoagulability, it can
distinguish between platelet-induced vs enzymatic hypercoagulability.
The decision tree is used to arrive, in a
systematic way, at a coagulopathy diagnosis. All the hemostasis
parameters are interdependent, and you need to evaluate the parameters
relative to each other, in addition to the patient's clinical status
and bleeding state, to determine if a coagulopathy is present, which
coagulopathy it is, and how to treat it.
Return to top
|
